EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanomedicine in Bladder Cancer Therapy

Adrianna Winnicka iD, Joanna Brzeszczyńska, Joanna Saluk iD, Paulina Wigner-Jeziorska iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910388 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Adrianna Winnicka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90-136 Lodz, Poland. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Nanomedicine. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre in Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer (BC) is one of the most common malignant neoplasms of the genitourinary system. Traditional BC therapies include chemotherapy, targeted therapy, and immunotherapy. However, limitations such as lack of specificity, cytotoxicity, and multidrug resistance pose serious challenges to the benefits of BC therapies. Consequently, current studies focus on the search for new therapeutic solutions. In recent years, there has been a growing interest in using nanotechnology in the treatment of both non-invasive (NMIBC) and invasive bladder cancer (MIBC). Nanotechnology is based on the use of both organic molecules (chitosan, liposomes) and inorganic molecules (superparamagnetic iron oxide nanoparticles) as carriers of active substances. The main aim of such molecules is the targeted transport and prolonged retention of the drug in the target tissue, which increases the therapeutic efficacy of the active substance. This review discusses the numerous types of nanoparticles (including chitosan, polymeric nanoparticles, liposomes, and protein nanoparticles), targeting mechanisms, and approved nanotherapeutics with oncological implications in cancer treatment. We also present nanoformulation applications in phototherapy, gene therapy, and immunotherapy. Moreover, we summarise the current perspectives, advantages, and challenges in clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNanomedicineHumansImmunotherapyAnimalsNanoparticlesLiposomesGenetic TherapyDrug Delivery SystemsAntineoplastic Agents

Stichwörter der Autor:innen

bladder cancercancer therapychitosannanoparticlesnanotechnology

Substanzen

LiposomesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90-136 Lodz, Poland.
  • Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-136 Lodz, Poland.

ORCID-Profile: Adrianna Winnicka, Joanna Saluk, Paulina Wigner-Jeziorska

Förderung

  • National Science Centre in Poland

Zitieren

APA

Winnicka, A., Brzeszczyńska, J., Saluk, J., & Wigner-Jeziorska, P. (2024). Nanomedicine in Bladder Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910388

Vancouver

Winnicka A, Brzeszczyńska J, Saluk J, Wigner-Jeziorska P. Nanomedicine in Bladder Cancer Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910388

BibTeX
@article{Winnicka2024,
  author = {Winnicka, Adrianna and Brzeszczyńska, Joanna and Saluk, Joanna and Wigner-Jeziorska, Paulina},
  title = {Nanomedicine in Bladder Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910388}
}
Kostenlos starten →